Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis
Background: Sleep disorders are commonly associated with acute and chronic use of alcohol and with abstinence. To date, there are four approved drugs to treat alcohol use disorder (AUD): disulfiram, acamprosate, naltrexone, and nalmefene. These AUD therapies reduce the craving and risk of relapse in...
Main Authors: | Francesca Panin, Alessandra T. Peana |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01164/full |
Similar Items
-
Brain Correlates of the Alcohol Use Disorder Pharmacotherapy Response: A Systematic Review of Neuroimaging Studies
by: Luiza Florence, et al.
Published: (2022-03-01) -
Veteran adherence to oral versus injectable AUD medication treatment
by: Hayden Stewart, PharmD, et al.
Published: (2021-05-01) -
The use of medications approved for alcohol use disorders in Italy
by: Filomena Fortinguerra, et al.
Published: (2023-02-01) -
The Association of P300 Components With Clinical Characteristics and Efficacy of Pharmacotherapy in Alcohol Use Disorder
by: Jing Yuan, et al.
Published: (2022-03-01) -
Practical outpatient pharmacotherapy for alcohol use disorder
by: Youngjung Kim, et al.
Published: (2018-02-01)